$32.88 -$1.62 (-4.7%)

04:30 PM EDT on 07/10/20

Editas Medicine (NASDAQ:EDIT)

CAPS Rating: 4 out of 5

Current Price $32.88 Mkt Cap $2.0B
Open $34.33 P/E Ratio 0.00
Prev. Close $32.88 Div. (Yield) $0.00 (0.0%)
Daily Range $32.59 - $34.93 Volume 770,628
52-Wk Range $14.01 - $36.78 Avg. Daily Vol. 1,213,346

Caps

How do you think NASDAQ:EDIT will perform against the market?

Add Stock to CAPS Watchlist

All Players

259 Outperform
8 Underperform
 

All-Star Players

145 Outperform
3 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:EDIT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

MarkFitzFool (84.47)
Submitted May 11, 2019

It's been a bumpy ride for Editas over the past few years, but such is the nature of being a developmental stage biotech company. What sets Editas apart is their leadership. Feng Zhang, one of the developers of both CRISPR and optogenetics, is a… More

LastPlaceLenny (69.00)
Submitted March 15, 2019

Not ready to take off yet, will out perform in long run, but not sure when that long run starts. Not this year.

NASDAQ:EDIT VS S&P 500 (SPY)

NASDAQ:EDIT Summary

Fools bullish on NASDAQ:EDIT are also bullish on:

Fools bearish on NASDAQ:EDIT are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about EDIT.

Recs

0
Member Avatar VetteNV (70.79) Submitted: 5/29/2020 10:27:43 PM : Outperform Start Price: $27.29 NASDAQ:EDIT Score: +15.22

Disruptive Bio Tech with royalty payments; Financial backing by ARK

Recs

0
Member Avatar BocaBi11 (96.47) Submitted: 5/26/2020 8:34:02 PM : Outperform Start Price: $27.29 NASDAQ:EDIT Score: +15.22

Blast Off

Recs

0
Member Avatar hmui (68.08) Submitted: 1/19/2020 11:22:49 AM : Outperform Start Price: $30.00 NASDAQ:EDIT Score: +13.99

Customized medicine in the treatment of the future.

Leaderboard

Find the members with the highest scoring picks in EDIT.

Score Leader

PAGEBOY73

PAGEBOY73 (98.31) Score: +120.59

The Score Leader is the player with the highest score across all their picks in EDIT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
freemarketmike < 20 6/7/2017 Outperform 5Y $15.43 +113.02% +30.50% +82.52 1 Comment
SeriousK 29.31 3/9/2016 Underperform 5Y $42.70 -23.01% +59.42% +82.43 0 Comment
WoollyWombat < 20 9/16/2016 Outperform 5Y $14.48 +127.04% +48.96% +78.08 0 Comment
portefeuille 99.10 2/10/2016 Outperform 5Y $13.26 +147.93% +70.44% +77.49 0 Comment
FunesDMemorious 31.29 10/26/2016 Outperform 5Y $14.55 +125.95% +49.06% +76.88 0 Comment
CMFMLove 75.54 6/13/2017 Outperform 5Y $16.00 +105.47% +30.26% +75.20 1 Comment
portefeuille2 99.37 9/22/2016 Outperform 5Y $14.87 +121.08% +46.48% +74.60 0 Comment
Playa14 < 20 6/9/2017 Outperform 5Y $16.08 +104.45% +30.21% +74.24 0 Comment
birdup 24.13 3/16/2020 Outperform 5Y $16.39 +100.64% +31.88% +68.76 0 Comment
Snappy85 95.18 7/10/2020 Underperform NS $96.89 -66.07% +0.92% +66.99 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for EDIT.